Spherix Incorporated (SPEX) financial statements (2021 and earlier)

Company profile

Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR
NEW YORK, NY 10020
State of Incorp. DE
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments28134001
Cash and cash equivalents3000001
Short-term investments25134   
Prepaid expense      0
Other undisclosed current assets0000644
Total current assets:28134644
Noncurrent Assets
Property, plant and equipment  00000
Intangible assets, net (including goodwill)   451057
Goodwill      2
Intangible assets, net (excluding goodwill)   451055
Deposits noncurrent assets   0000
Other undisclosed noncurrent assets310101   
Total noncurrent assets:31010551057
TOTAL ASSETS:3011139111461
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1000001
Accrued liabilities  0000 
Employee-related liabilities0111010
Other undisclosed accounts payable and accrued liabilities0(1)(1)(1)(0)(0)0
Debt   0000
Other undisclosed current liabilities0112240
Total current liabilities:1113341
Noncurrent Liabilities
Liabilities, other than long-term debt   2300
Deferred revenue and credits2300
Total noncurrent liabilities:   2300
Total liabilities:1115652
Stockholders' equity
Stockholders' equity attributable to parent30111245954
Common stock0 0   0
Treasury stock, value(0)(0)(0)(0)(0)(0)(0)
Additional paid in capital186155152149147144138
Accumulated deficit(157)(144)(140)(145)(142)(135)(84)
Other undisclosed stockholders' equity      6
Total stockholders' equity:30111245960
TOTAL LIABILITIES AND EQUITY:3011139111461

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues0001100
Revenue, net  0 
Net investment income 000001
Other income00(0)0(0)0
Cost of revenue (0)     
Gross profit:0 01100
Operating expenses(7)(6)(7)(5)(9)(52)(31)
Other undisclosed operating income (loss)(0)0     
Operating loss:(7)(6)(7)(4)(9)(52)(31)
Nonoperating income (expense)(6)291210
Investment income, nonoperating 180   
Other nonoperating expense(6)      
Interest and debt expense    (5)(10) 
Income (loss) from continuing operations before income taxes:(12)(4)2(3)(11)(61)(31)
Income tax expense      (5)
Net income (loss):(12)(4)2(3)(11)(61)(36)
Other undisclosed net income attributable to parent    5105
Net income (loss) attributable to parent:(12)(4)2(3)(6)(51)(31)
Preferred stock dividends and other adjustments    31(9) 
Other undisclosed net income available to common stockholders, basic     18 
Net income (loss) available to common stockholders, diluted:(12)(4)2(3)25(42)(31)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(12)(4)2(3)(11)(61)(36)
Comprehensive income (loss), net of tax, attributable to parent:(12)(4)2(3)(11)(61)(36)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: